Monday, November 9, 2020

American Thoracic Society Member Education and Research Benefits



Dr. Jason Jaramillo earned his doctor of medicine in 2005, and for 15 years he has been working in healthcare leadership positions. In 2017, Jason Jaramillo, MD, presented the work “Achromobacter Xylosoxidans And Enterovirus-Rhinovirus Co-Infection Causing Ards In A Patient With An Underlying Genetic Condition” at a meeting of the American Thoracic Society (ATS), held in Washington, D.C..

ATS is an international society with over 16,000 members dedicated to advancing the science and clinical understanding of critical illnesses, pulmonary diseases, and sleep-related breathing disorders. The ATS membership program is offered to physicians, nurses, researchers, respiratory therapists, and other professionals interested in the organization and its mission to study, prevent, and eradicate lung disease.

The program grants these professionals several educational and research benefits, including access to leading-edge publications and medical journals, such as the American Journal of Respiratory and Critical Care Medicine and email subscriptions to the ATS News and the ATS Morning Minute. Members also receive discounted access to the Methods in Epidemiologic, Clinical, and Operations Research (MECOR) program, which prepares practitioners and researchers to plan and conduct industry-relevant investigations. Besides the MECOR program discounts, ATS members pay reduced fees for admission to the International Conference and when purchasing the Respiratory Medicine Book Series. 

Friday, October 16, 2020

How ARDS Affects the Lung

The recipient of a 2015 co-intern of the year award, Jason Jaramillo, MD, serves as a physician at Maimonides Medical Center. In 2017, at the national meeting of the American Society of Thoracic Surgeons held in Washington, D.C., Dr. Jason Jaramillo did a poster presentation titled “Achromobacter Xylosoxidans And Enterovirus-Rhinovirus Co-Infection Causing ARDS In A Patient With An Underlying Genetic Condition.”


A condition that often causes lung failure, acute respiratory distress syndrome (ARDS) happens when a patient has difficulty breathing as a result of leakage of fluid in the lungs. The fluid leaks from inflamed small vessels within the alveoli (tiny air sacs in the lungs). This can result from a serious injury to the body such as an accident, pneumonia, swelling of the pancreas, a serious infection, and the inhalation of toxic substances like smoke. The condition may also result from a blood transfusion.

The fluid in the lung makes it stiff. This stiffness causes hypoxemia, which is characterized by low oxygen in the blood, resulting - in this case - from difficulty inflating the lung. If the inflammation worsens and more fluid accumulates, the lung scars (the fibrotic stage of ARDS). During this stage, the lung may eventually collapse.

Tuesday, September 29, 2020

The American Board of Internal Medicine's MOC Program

 

Friday, August 28, 2020

About Acute Respiratory Distress Syndrome

 

Tuesday, March 31, 2020

Rhinovirus Infection Symptoms